Envestnet Asset Management »

Intra Cellular Therapies shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.9M 129k 69.20
2023-09-30 $6.6M 127k 52.09
2023-06-30 $5.1M 81k 63.32
2023-03-31 $4.0M 73k 54.15
2022-12-31 $3.0M 57k 52.92
2022-09-30 $2.7M 59k 46.53
2022-06-30 $207k 3.6k 57.07

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Envestnet Asset Management

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Geode Capital Management
Alliancebernstein
Wellington Management Company
Jpmorgan Chase & Co
ClearBridge Advisors
Franklin Resources
Jennifer Ranahan
T. Rowe Price Associates
Avidity Partners Management

View all funds holding Intra Cellular Therapies